As the United Kingdom’s FTSE 100 index experiences fluctuations due to global economic pressures, such as weak trade data from China, investors are increasingly looking beyond blue-chip stocks to find opportunities in lesser-known sectors. In this environment, identifying promising small-cap companies with strong fundamentals and growth potential can be a strategic approach for those seeking to navigate the current market landscape.
Name
Debt To Equity
Revenue Growth
Earnings Growth
Health Rating
Goodwin
24.30%
12.58%
22.87%
★★★★★★
Andrews Sykes Group
NA
2.01%
5.12%
★★★★★★
BioPharma Credit
NA
5.72%
5.22%
★★★★★★
Georgia Capital
NA
13.71%
21.08%
★★★★★★
Audioboom Group
NA
11.20%
-12.30%
★★★★★★
Nationwide Building Society
282.42%
9.69%
21.24%
★★★★★☆
FW Thorpe
2.19%
9.09%
11.33%
★★★★★☆
Foresight Environmental Infrastructure
NA
-24.80%
-27.25%
★★★★★☆
Strategic Minerals
NA
4.81%
-40.63%
★★★★★☆
Distribution Finance Capital Holdings
12.97%
42.17%
59.43%
★★★★☆☆
Let’s explore several standout options from the results in the screener.
Simply Wall St Value Rating: ★★★★☆☆
Overview: Optima Health plc offers occupational health and wellbeing services to both public and private sectors in the UK, with a market capitalization of £210.48 million.
Operations: Optima Health generates revenue primarily from the provision of occupational health and wellbeing services, amounting to £113.75 million.
Optima Health, a budding player in the healthcare sector, recently turned profitable and is trading at 57% below its estimated fair value. Its net debt to equity ratio stands at a satisfactory 2.8%, while interest payments are well covered with EBIT providing 4.9x coverage. The company has seen shareholder dilution over the past year and completed a follow-on equity offering of £35 million this April, priced at £1.75 per share. A strategic partnership with Perkbox is expected to add GBP 6.5 million annually, enhancing its service offerings in employee assistance programs and mental health services.
AIM:OPT Earnings and Revenue Growth as at Apr 2026
Simply Wall St Value Rating: ★★★★★★
Overview: Georgia Capital PLC is a private equity and venture capital firm focused on early-stage investments, organic growth, and acquisitions, with a market cap of £1.22 billion.
Operations: Georgia Capital generates revenue through its private equity and venture capital investments, focusing on early-stage companies and acquisitions. The firm operates with a market cap of £1.22 billion, emphasizing organic growth within its portfolio.
Georgia Capital, a nimble player in the market, has shown remarkable growth with earnings surging by 422% over the past year, outpacing its industry peers. The company reported an impressive net income of GEL 1.89 billion for 2025, a significant leap from GEL 362 million the previous year. Despite not being free cash flow positive, Georgia Capital remains debt-free and trades at a slight discount to its estimated fair value. Its high level of non-cash earnings suggests robust underlying operations, positioning it as an intriguing prospect in the financial landscape of the United Kingdom.
LSE:CGEO Debt to Equity as at Apr 2026
Simply Wall St Value Rating: ★★★★★☆
Overview: Pollen Street Group, founded in 2015 and headquartered in London, operates as an investment management company with a market capitalization of approximately £502.09 million.
Operations: Pollen Street Group generates revenue primarily from its Asset Manager and Investment Company segments, with figures of £81.08 million and £62.65 million, respectively. The Central segment reported a negative contribution of -£9.21 million.
Pollen Street Group, a financial player in the UK, showcases impressive figures with its debt to equity ratio dropping from 76.6% to 33.4% over five years, indicating prudent financial management. Its price-to-earnings ratio of 8.9x is notably below the UK market average of 16x, suggesting potential undervaluation. The company also boasts high-quality earnings and satisfactory interest coverage at five times its interest payments through EBIT. Despite a net income rise to £56.57 million from £49.6 million last year, earnings growth slightly lagged behind industry peers recently; however, robust free cash flow and strategic dividend increases underscore strong shareholder returns prospects.
LSE:POLN Earnings and Revenue Growth as at Apr 2026
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AIM:OPT LSE:CGEO and LSE:POLN.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com